Jacqueline Claire Lupo
Director Ejecutivo en LOPHOS HOLDINGS INC. .
Fortuna: 660 000 $ al 30/04/2024
Perfil
Jacqueline Claire Lupo is the founder of Lophos Pharmaceuticals Corp., where she holds the title of President, CEO & Director since 2021.
She is also the founder of Canalytica Corp.
Ms. Lupo's current job is as the Chief Executive Officer & Director at Lophos Holdings, Inc. since 2021.
Additionally, she is currently working as a Manager at Northern Green Canada, Inc.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LOPHOS HOLDINGS, INC.
14.90% | 12/02/2024 | 11 000 000 ( 14.90% ) | 660 000 $ | 30/04/2024 |
Cargos activos de Jacqueline Claire Lupo
| Empresas | Cargo | Inicio |
|---|---|---|
| LOPHOS HOLDINGS INC. | Director Ejecutivo | 23/12/2021 |
Lophos Pharmaceuticals Corp.
 Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022. | Fundador | 01/01/2021 |
| Northern Green Canada, Inc. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Jacqueline Claire Lupo.
| Empresas | Cargo | Fin |
|---|---|---|
| Canalytica Corp. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| LOPHOS HOLDINGS INC. | Process Industries |
| Empresas privadas | 3 |
|---|---|
| Northern Green Canada, Inc. | Consumer Non-Durables |
Lophos Pharmaceuticals Corp.
Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022. | Health Technology |
| Canalytica Corp. |
- Bolsa de valores
- Insiders
- Jacqueline Claire Lupo